Analysts Raise HCA Healthcare EPS to $30.01; Institutional Stake Climbs 52.5%
Seven analysts raised HCA Healthcare’s fiscal 2026 EPS estimate by $0.36 to $30.01, reflecting a 13.6% average earnings surprise and underpinning a 6.4% earnings growth forecast. In addition, Cresset Asset Management increased its position by 52.5% to 4,141 shares, indicating growing institutional support.
1. Analyst Revisions Boost EPS Outlook
Seven analysts raised HCA Healthcare’s fiscal 2026 EPS estimate by $0.36 to $30.01 over the past 60 days, driving a 13.6% average earnings surprise. This collective upward adjustment underpins a projected 6.4% increase in earnings for the current fiscal year, reflecting improved profitability expectations.
2. Institutional Ownership Increases
Cresset Asset Management boosted its HCA position by 52.5%, acquiring an additional 1,425 shares to hold 4,141 total. This marked increase by a value-oriented fund highlights growing institutional confidence in the company’s outlook.
3. Focus List Performance and Operations
Since its January 2019 inclusion in a top-ranked Focus List, HCA Healthcare shares have surged 331.8%. The Nashville-based operator now runs 190 acute care hospitals and roughly 2,500 ambulatory sites across 19 U.S. states and the U.K., illustrating its broad scale and growth trajectory.